Working… Menu

A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors (HICKORY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02100696
Recruitment Status : Completed
First Posted : April 1, 2014
Last Update Posted : May 8, 2020
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 16, 2020
Actual Study Completion Date : April 16, 2020
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 April 9, 2021